Voyager Therapeutics Inc (VYGR)
8.43
-0.20
(-2.32%)
USD |
NASDAQ |
May 17, 16:00
8.43
0.00 (0.00%)
After-Hours: 20:00
Voyager Therapeutics Research and Development Expense (Quarterly): 27.09M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 27.09M |
| December 31, 2023 | 25.76M |
| September 30, 2023 | 25.86M |
| June 30, 2023 | 21.98M |
| March 31, 2023 | 18.57M |
| December 31, 2022 | 14.55M |
| September 30, 2022 | 19.34M |
| June 30, 2022 | 12.53M |
| March 31, 2022 | 14.35M |
| December 31, 2021 | 14.02M |
| September 30, 2021 | 17.91M |
| June 30, 2021 | 19.50M |
| March 31, 2021 | 22.35M |
| December 31, 2020 | 22.00M |
| September 30, 2020 | 25.04M |
| June 30, 2020 | 29.42M |
| March 31, 2020 | 32.29M |
| December 31, 2019 | 36.55M |
| September 30, 2019 | 29.78M |
| June 30, 2019 | 28.58M |
| Date | Value |
|---|---|
| March 31, 2019 | 24.83M |
| December 31, 2018 | 16.91M |
| September 30, 2018 | 16.63M |
| June 30, 2018 | 16.51M |
| March 31, 2018 | 14.85M |
| December 31, 2017 | 13.33M |
| September 30, 2017 | 19.56M |
| June 30, 2017 | 15.30M |
| March 31, 2017 | 14.07M |
| December 31, 2016 | 12.72M |
| September 30, 2016 | 10.31M |
| June 30, 2016 | 10.48M |
| March 31, 2016 | 8.732M |
| December 31, 2015 | 9.22M |
| September 30, 2015 | 6.481M |
| June 30, 2015 | 6.455M |
| March 31, 2015 | 5.523M |
| December 31, 2014 | 2.96M |
| September 30, 2014 | 2.399M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
12.53M
Minimum
Jun 2022
36.55M
Maximum
Dec 2019
22.87M
Average
22.17M
Median
Research and Development Expense (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 5.971M |
| Stereotaxis Inc | 2.243M |
| United Therapeutics Corp | 104.10M |
| MEI Pharma Inc | 5.22M |
| Agios Pharmaceuticals Inc | 68.62M |